ESC 365 - Doctor Anca Daniela Farcas

Speaker illustration

Doctor Anca Daniela Farcas

University of Medicine and Pharmacy of Cluj Napoca, Cluj Napoca (Romania)

Member of:

Heart Failure Association

Could diastolic perfomance parameters be earlier markers for cardiotoxicity in high risk cancer patients?

Event: ESC Congress 2020

Topic: Cardio-Oncology

Session: Cardiovascular Disease in Special Populations ePosters

The role of ST2 as an early marker of endothelial dysfunction in hypertensive patients

Event: ESC Congress 2019

Topic: Target Organ Damage/Left Ventricular Hypertrophy

Session: Hypertension mediated target organ damage and hypertension phenotypes

Plasma levels of ST2 - predictive factor of unfavourable outcome in hypertensive patients

Event: ESC Congress 2018

Topic: Epidemiology, Prognosis, Outcome

Session: Hypertension treatment old and new

Heart failure with mid-range ejection fraction - an echocardiographic finding or a clinical phenotype?

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Topic: Chronic pulmonary hypertension

Session: Chronic heart failure

Metoprolol and carvedilol in heart failure - different mechanisms, similar effect?

Event: Heart Failure 2017 - 4th World Congress on Acute Heart Failure

Topic: Beta blockers

Session: Beta blockers

Improving blood pressure control beyond the guidelines

Event: ESC Congress 2016

Topic: Treatment of hypertension

Session: Drug treatment of hypertension

The lymphocyte count and neutrophil/lymphocyte ratio as independent predictors for cardiac events in heart failure only in ischemic heart disease patients

Event: HEART FAILURE 2016

Topic: Inflammation

Session: Biomarkers

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources